Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0001209191-20-023991

Options or other derivatives

  • Chief Executive Officer acquired 696,569 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Seehra Jasbir Chief Executive Officer 2020-04-07 Grant or award · Employee Stock Option (right to buy) +696,569 696,569 D: show line 1 in the form
Loading xslF345X03/doc4.xml…